Health-care providers, the Trump administration, and manufacturers like Becton Dickinson and Co. are preparing for the next Covid-19 supply shortage—needles and syringes essential to delivering vaccines.
The Department of Health and Human Services has signed contracts to get an additional 320 million needles and syringes, and companies are ramping up their production.
The moves come as officials foresee an increased demand for needles and syringes with more people seeking a flu shot this year and governments trying to secure inventory for a possible Covid-19 vaccine.
The Trump administration is working to speed a Covid-19 vaccine to market amid a rising ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.